Bexagliflozin
Bexagliflozin is an SGLT2 inhibitor, antidiabetic drug.
| Catalog Number | API0232512 |
| Alternative Name(s) | Bexagliflozin; 1118567-05-7; EGT1442 |
| Research Area | API |
| Molecular Formula | C24H29ClO7 |
| CAS# | 1118567-05-7 |
| Inchi | InChI=1S/C24H29ClO7/c25-19-8-3-15(24-23(29)22(28)21(27)20(13-26)32-24)12-16(19)11-14-1-4-17(5-2-14)30-9-10-31-18-6-7-18/h1-5,8,12,18,20-24,26-29H,6-7,9-11,13H2/t20-,21-,22+,23-,24+/m1/s1 |
| Inchi Key | BTCRKOKVYTVOLU-SJSRKZJXSA-N |
| SMILES | C1CC1OCCOC2=CC=C(C=C2)CC3=C(C=CC(=C3)[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)Cl |
| Size | inquiry |
| Supplier Page | https://apihub.protheragen.ai/bexagliflozin-item-1012.html |